QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bae, Y.-S. Articles by Ho Ryu, S. Search for Related Content PubMed PubMed Citation Articles by Bae, Y.-S. Articles by Ho Ryu, S.

Differential Signaling of Formyl Peptide Receptor-Like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH₂ or Lipoxin A4 in Human Neutrophils

Medical Research Center for Cancer Molecular Therapy and Department of Biochemistry College of Medicine, Dong-A University, Busan, Korea (Y.-S.B., J.-Y.K.); Division of Molecular and Life Sciences, Pohang University of Science and Technology, Pohang, Korea (J.C.P., P.-G.S., S.H.R.); and Department of Pharmacology, University of Illinois, Chicago, Illinois (R.H., R.D.Y.).

Received July 24, 2002; accepted May 30, 2003

	Abstract

Top Abstract Materials and Methods Results Discussion References

 
Classical chemoattractant receptors are of fundamental importance to immune responses. The two major roles of such receptors are the modulation of chemotaxis and the generation of reactive oxygen species. The formyl peptide receptor-like 1 (FPRL1) can be stimulated by two different ligands, Trp-Lys-Tyr-Met-Val-Met-CONH₂ (WKYMVM) and lipoxin A4 (LXA4). Although leukocyte chemotaxis mediated by activated FPRL1 has been reported, the role of FPRL1 in superoxide generation remains to be studied. In this study, we examined the effect of WKYMVM or LXA4 on chemotactic migration and superoxide generation in human neutrophils. WKYMVM and LXA4 stimulated neutrophil chemotaxis via tyrosine phosphorylation events. In terms of reactive oxygen species generation, WKYMVM but not LXA4 stimulated superoxide generation in neutrophils. To understand this difference on superoxide generation via the same receptor, FPRL1, we compared the signaling pathways downstream of FPRL1 by the two different ligands. At first, we confirmed that both WKYMVM and LXA4 caused intracellular calcium ([Ca²⁺]_i) increase in a pertussis toxin-sensitive manner and that these ligands competitively inhibited each other with respect to [Ca²⁺]_i increase in neutrophils. This result suggests that WKYMVM and LXA4 share the same receptor, FPRL1. By investigating cellular signaling by WKYMVM and LXA4, we found that WKYMVM but not LXA4 induced extracellular signal-regulated protein kinases (ERKs), c-Jun NH₂-terminal kinase, and phospholipase A₂ (PLA₂) activation. We also found that ERK-mediated cytosolic PLA₂ activity is essential for superoxide generation. These results indicate that the activation of FPRL1 by the two different ligands can induce differential cellular signaling and unique functional consequences in human neutrophils.

Because these chemoattractants have important roles in the modulation of host immunity, their molecular interactions with receptors and the subsequently induced cellular signaling pathways have received much attention (Le et al., 2001b). The formyl peptide receptor (FPR) system is one of the most extensively studied chemoattractant receptor systems. When fMLF binds to FPR, FPR transmits a signal to the heterotrimeric G proteins, which induces the activation of phospholipase C (PLC) and phophoinositide-3-kinase (PI3K) (Jiang et al., 1996; Pan et al., 2000). PLC then hydrolyzes phosphatidylinositol 4,5-bisphosphate into phosphatidylinositol 1,4,5-triphosphate and diacylglycerol, which induce intracellular calcium ([Ca²⁺]_i) increase and protein kinase C activation, respectively (Rhee and Bae, 1997). Moreover, PI3K converts phosphatidylinositol 4,5-bisphosphate into phosphatidylinositol 1,4,5-triphosphate, which is essential for modulating cellular enzymes, including 3-phosphoinositide–dependent protein kinase 1 (Shepherd et al., 1998). The downstream signaling initiated by fMLF binding also induces other signaling cascades, which include mitogen-activated protein kinases (MAPKs), phospholipase A₂ (PLA₂), and phospholipase D (PLD) activation (Marshall et al., 2000; Bechoua and Daniel, 2001).

FPR and two homologs of FPR have been identified in humans: formyl peptide receptor-like 1 (FPRL1) and formyl peptide receptor-like 2 (FPRL2) (Le et al., 2001b). Recently, several different agonists have been identified for FPR and FPRL1 (Le et al., 2001b). One of the natural ligands for FPRL1 is lipoxin A4 (LXA4), an eicosanoid (Maddox et al., 1997). Although FPRL1 is important in the modulation of inflammatory responses, by mediating the recruitment of leukocytic cells into an infected area, its downstream signaling pathway has not been examined. Previously, we reported on a synthetic peptide, Trp-Lys-Tyr-Met-Val-Met-CONH₂ (WKYMVM), that can stimulate leukocyte activity (Baek et al., 1996). WKYMVM was found to stimulate phosphoinositide hydrolysis and extracellular signal-regulated protein kinase (ERK) activation in U937 cells, and these events proved to be PTX-sensitive, suggesting the involvement of PTX-sensitive G protein (Baek et al., 1996, 1999). Recently Christophe et al. (2001) demonstrated that WKYMVM is also a ligand for FPRL1. In this study, we compared the signaling pathways and functional consequences downstream of FPRL1 ligation by WKYMVM and LXA4 in human neutrophils.

	Materials and Methods

Top Abstract Materials and Methods Results Discussion References

 
Materials. WKYMVM was synthesized and purified in the Peptide Library Support Facility at Pohang University of Science and Technology, as described previously (Baek et al., 1996). RPMI 1640 was purchased from Invitrogen (Carlsbad, CA). Amyloid peptide 1–42 (A42) was purchased from Bachem Bioscience (King of Prussia, PA). Human interleukin-8 (IL-8) was obtained from Genzyme (Cambridge, MA). Dialyzed fetal bovine serum and supplemented bovine calf serum were from Hyclone Laboratories (Logan, UT). Pertussis toxin and [9,10(n)-³H]myristic acid (53 Ci/mmol) were from Amersham Biosciences UK, Ltd. (Little Chalfont, Buckinghamshire, UK). [5,6,8,9,11,12,14,15-³H]arachidonic acid (AA) (100 Ci/mmol) was from PerkinElmer Life Sciences (Boston, MA). Precoated silica gel TLC plates (F-254) were from Merck (Darmstadt, Germany); GF109203X, Ro-31–8220, LY294002, and genistein were from Calbiochem (San Diego, CA); 5(S),6(R),15(S)-trihydroxyeicosa-7E,9E,11Z,13E-tetraenoic acid (lipoxin A4), methyl arachidonylfluorophosphonate (MAFP), arachidonyltrifluoromethyl ketone (AACOCF₃), and bromoenol lactone (BEL) were from BIOMOL Research Laboratories (Plymouth Meeting, PA); rabbit anti-human antibodies to ERK2, phospho-ERKs, JNK, phospho-JNK, and phospho-paxillin (Y118) were from Cell Signaling Technology Inc. (Beverly, MA), and horseradish peroxidase-conjugated antibodies to mouse and rabbit IgG were purchased from Kirkegaard and Perry Laboratories (Gaithersburg, MD).

Isolation of Human Neutrophils. Peripheral blood was collected from healthy donors, and human neutrophils were isolated by dextran sedimentation, hypotonic lysis of erythrocytes, and by using a lymphocyte separation medium gradient as described previously (Bae et al., 2001). Isolated human neutrophils were used promptly.

Cell Culture. RBL-2H3 cells and FPRL1-expressing RBL-2H3 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 20% FBS and 200 µg/ml of G418, as described previously (He et al., 2000).

Measurement of [Ca²⁺]_i. The level of [Ca²⁺]_i was determined by Grynkiewicz's method using fura-2/AM (Bae et al., 2001). Briefly, prepared cells were incubated with 3 µM of fura-2/AM at 37°C for 50 min in fresh serum-free RPMI 1640 medium with continuous stirring. Cells (2 x 10⁶) were aliquoted for each assay into Ca²⁺-free Locke solution (154 mM NaCl, 5.6 mM KCl, 1.2 mM MgCl₂, 5 mM HEPES, pH 7.3, 10 mM glucose, and 0.2 mM EGTA). Fluorescence changes at two excitation wavelengths (340 and 380 nm) and an emission wavelength of 500 nm were measured, and the fluorescence ratio obtained was translated into [Ca²⁺]_i.

Chemotaxis Assay. Chemotaxis assays were performed using multiwell chambers (Neuroprobe Inc., Gaithersburg, MD) (Bae et al., 2001). Briefly, prepared human neutrophils were suspended in RPMI 1640 medium at a concentration of 1 x 10⁶ cells/ml, and 25 µl of this suspension was placed on the upper well of a chamber onto a 3-µm polyhydrocarbon filter, which separated the suspension from the WKYMVM- or LXA4-containing lower well. After incubation for 2 h at 37°C, nonmigrated cells were removed by scraping. Cells that migrated across the filter were dehydrated, fixed, and stained with hematoxylin (Sigma, St. Louis, MO) and were counted in five randomly chosen high-power fields (400x).

Stimulation of Cells with WKYMVM or LXA4. Prepared cells were aliquoted into 2 x 10⁶ cells and stimulated with the indicated concentrations of WKYMVM or LXA4 for predetermined periods. After stimulation, the cells were washed with serum-free RPMI 1640 medium and lysed in lysis buffer (20 mM HEPES, pH 7.2, 10% glycerol, 150 mM NaCl, 1% Triton X-100, 50 mM NaF, 1 mM Na₃VO₄, 10 µg/ml of leupeptin, 10 µg/ml of aprotinin, and 1 mM phenylmethylsulfonyl fluoride). The detergent-insoluble material was pelleted by centrifugation (12,000g for 15 min at 4°C), and the soluble supernatant fraction was removed and stored at –80°C or used immediately. Protein concentrations in the lysates were determined using Bradford protein assay reagent.

Electrophoresis and Immunoblot Analysis. Protein samples were prepared for electrophoresis by adding concentrated Laemmli sample buffer and separated using an 8% SDS-polyacrylamide gel and a buffer system described previously (Bae et al., 2000). After electrophoresis, the proteins were blotted onto a nitrocellulose membrane, which was then blocked by incubation with Tris-buffered saline/0.05% Tween 20 containing 5% nonfat dry milk. The membranes were then incubated with anti–phospho-ERK antibody, anti-ERK antibody, anti–phospho-JNK antibody, or anti-JNK antibody and washed with Tris-buffered saline. Antigen-antibody complexes were visualized after incubating the membrane with 1:5,000 diluted goat anti-rabbit IgG or goat anti-mouse IgG antibody coupled to horseradish peroxidase by using the enhanced chemiluminescence detection system.

Measurement of Superoxide Anion Generation. Superoxide anion generation was determined by measuring cytochrome c reduction using a microtiter 96-well plate enzyme-linked immunosorbent assay reader (EL312e; Bio-Tek Instruments, Winooski, VT) as described previously (Bae et al., 2001). Human neutrophils (2 x 10⁶ cells in RPMI 1640 medium) were preincubated with 50 µM of cytochrome c at 37°C for 1 min and then incubated with 100 nM of WKYMVM. To study the roles of PLA₂ and PLD in peptide-induced superoxide generation, aliquots of cells were pretreated with 20 µM of the PLA₂ inhibitor butan-1-ol or butan-3-ol before peptide stimulation. Superoxide generation was determined by measuring changes of light absorption at 550 nm over 5 min at 1-min intervals.

Measurement of Phosphatidylbutanol Formation in Human Neutrophils. Phosphatidylbutanol (PBt) production was determined as described in an earlier report (Bae et al., 2000) with a slight modification. Briefly, human neutrophils were resuspended to 1 x 10⁶ cells/ml in RPMI 1640 medium containing 2.5% FBS and loaded with [³H]myristic acid (5 µCi/ml) for 90 min at 37°C. The loaded neutrophils were then washed twice with serum-free RPMI 1640 medium and stimulated with WKYMVM in the presence of 0.5% butan-1-ol. After 30 min, the reaction was quenched by adding 0.5 ml of ice-cold methanol, and the medium was aspirated. Chloroform (1 ml) and 0.5 ml of 1 M NaCl were then added to the medium, and total lipids were extracted by vigorous vortexing. The lower chloroform phase was obtained by centrifuging at 550g for 10 min and dried under nitrogen. The lipids were then dissolved in chloroform-methanol (95:5), spotted onto silica gel 60 TLC plates, and separated using a solvent containing chloroform-methanol-acetic acid (90:10:10), as described previously (Bae et al., 2000). The amounts of PBt and total lipid were determined using a Fuji BAS-2000 image analyzer (Fuji Photo Film Co., Ltd., Tokyo, Japan).

Measurement of PLA₂ Activity in Cells. Isolated human neutrophils (10⁷ cells/ml) were prelabeled with 0.5 µCi/ml of [³H]AA in RPMI 1640 medium containing 10% FBS at 37°C for 24 h in a humidified incubator supplied with 95% air and 5% CO₂, as described previously (Bae et al., 2000). The labeled cells were then washed twice with serum-free RPMI 1640 and incubated in RPMI 1640 medium containing 0.1% fatty acid-free BSA for 15 min at 37°C. After discarding the medium, the cells were stimulated with various concentrations of WKYMVM for the indicated times. The radioactivities of the medium and of the collected cells were measured using a liquid scintillation counter. When investigating the effects of inhibitors on the WKYMVM-stimulated PLA₂ activity, the cells were preincubated with the indicated concentrations of each inhibitor, or vehicle, for 15 min before stimulation.

	Results

Top Abstract Materials and Methods Results Discussion References

 
WKYMVM and LXA4 Stimulate [Ca²⁺]_i Increase in a PTX-Sensitive Manner in Human Neutrophils. Many chemoattractants that bind to specific GPCRs induce phosphoinositide hydrolysis and [Ca²⁺]_i increase (Bokoch, 1995; Jiang et al., 1996; Le et al., 2001b). In this study, we examined the effects of WKYMVM and LXA4 on [Ca²⁺]_i changes in human neutrophils. Fura-2–loaded human neutrophils were stimulated with various concentrations of WKYMVM or LXA4. As shown in Fig. 1A, WKYMVM or LXA4 caused [Ca²⁺]_i increase in a concentration-dependent manner, showing maximal activity at 30 and 100 nM, respectively. The effect of WKYMVM or LXA4 on calcium activity was consistently observed with different donors. In a parallel experiment, we also verified the effect of WKYMVM or LXA4 on [Ca²⁺]_i increase in HL60 (dHL60) cells differentiated by DMSO. Both WKYMVM and LXA4 were found to stimulate [Ca²⁺]_i increase in the dHL60 cells with similar potencies as in neutrophils (data not shown). This result further supports our observation that LXA4 stimulates human neutrophils to induce [Ca²⁺]_i increase. The majority of chemoattractants have been found to bind to a family of receptors that are coupled to PTX-sensitive G proteins (Bokoch, 1995; Le et al., 2001b). Thus, we examined the effect of PTX on WKYMVM or LXA4-induced [Ca²⁺]_i increase. When neutrophils were pre-incubated with 100 ng/ml of PTX for 24 h, WKYMVM- or LXA4-induced cytosolic calcium changes were completely inhibited (Fig. 1B). As a control experiment, we checked the effect of UTP, which stimulates myeloid cells in a PTX-insensitive manner, on [Ca²⁺]_i increase in PTX-treated neutrophils (Alemany et al., 2000). We confirmed that UTP-induced [Ca²⁺]_i increase was not affected by PTX treatment (Fig. 1B). These results indicate that both WKYMVM and LXA4 stimulate [Ca²⁺]_i increase in human neutrophils and that these events occur in a PTX-sensitive G protein-dependent manner.

View larger version (22K): [in this window] [in a new window]   Fig. 1. Both WKYMVM and LXA4 stimulate [Ca2+]i increase in human neutrophils. A, human neutrophils were loaded with 3 µM fura-2/AM for 50 min at 37°C in serum-free RPMI 1640 medium and washed three times with serum-free RPMI 1640. Before measurement, the cells (2 x 106) were suspended in Ca2+-free Locke solution containing 0.2 mM EGTA. Fura-2–loaded cells were stimulated with various concentrations of WKYMVM or LXA4. Maximum [Ca2+]i increases were noted. Data are presented as means ± S.E.M. of four independent experiments. B, isolated human neutrophils were preincubated in the absence or presence of 100 ng/ml of PTX for 24 h at 37°C in a 5% CO2 incubator. Cells were then loaded with fura-2, and the [Ca2+]i increases because of additions of 100 nM of WKYMVM, 1 µM of LXA4, or 100 µM UTP were measured. The charts shown are from a single experiment and are representative of three independent experiments. FL, fluorescence.

WKYMVM and LXA4 Stimulate Neutrophils via FPRL1. LXA4 has been reported to be a lipid agonist for FPRL1 (Maddox et al., 1997). Recently, it was also demonstrated that WKYMVM could activate FPRL1 but not FPR (Christophe et al., 2001). Because WKYMVM and LXA4 are specific agonists for FPRL1, we checked whether the two agonists competitively increase [Ca²⁺]_i. As shown in Fig. 2A, the stimulation of neutrophils with WKYMVM caused the complete inhibition of LXA4-induced [Ca²⁺]_i increase. Similarly, LXA4 pretreatment also completely inhibited WKYMVM-induced [Ca²⁺]_i increase (Fig. 2A). These results suggest that WKYMVM and LXA4 share the same receptor in neutrophils and further suggest that WKYMVM and LXA4 stimulate human neutrophils via FPRL1. To confirm that WKYMVM and LXA4 act on the same receptor, FPRL1, on the surface of human neutrophils, we investigated the effect of A42 on WKYMVM or LXA4 signaling. A42 is a well-known FPRL1-specific agonist (Le et al., 2001a). When human neutrophils were pretreated with A42, [Ca²⁺]_i increase by WKYMVM- or LXA4 was completely inhibited (Fig. 2B). The result strongly supports our notion that WKYMVM and LXA4 act on FPRL1 in the cells. We also investigated the effect of WKYMVM or LXA4 on the [Ca²⁺]_i increase by IL-8, a specific ligand of IL-8 receptor. Pretreatment of WKYMVM or LXA4 did not affect on the IL-8–induced [Ca²⁺]_i increase in human neutrophils (Fig. 2C). This result suggests that inhibition of LXA4-induced signaling caused by WKYMVM pretreatment is mediated through specific desensitization of FPRL1 but not through other receptors.

View larger version (21K): [in this window] [in a new window]   Fig. 2. WKYMVM and LXA4 act on the same receptor, FPRL1, in human neutrophils. A, fluorescence (FL) ratios of fura-2–loaded human neutrophils were monitored before and during the sequential addition of agonists (100 nM WKYMVM or 1 µM LXA4) at the times indicated by the arrows. B, 20 µM A42, 100 nM WKYMVM, or 1 µM LXA4 were used. C, 100 nM WKYMVM, 1 µM LXA4, or 1 ng/ml IL-8 were used. The charts shown are from a single experiment, which was representative of at least three independent experiments (A, B, and C).

WKYMVM and LXA4 Induce Neutrophil Chemotaxis via Tyrosine Phosphorylation. FPRL1 is one of the classic chemoattractant receptors (Le et al., 2001b). Because WKYMVM and LXA4 have been reported to be ligands of FPRL1, we examined the effect of WKYMVM or LXA4 on neutrophil chemotaxis. As shown in Fig. 3A, WKYMVM induced neutrophil chemotaxis within the concentration range of 1 to 500 nM; similarly, LXA4 also caused neutrophil chemotaxis in the range of 10 to 500 nM (Fig. 3A). WKYMVM induced neutrophil chemotaxis more potently than did LXA4. A number of reports have shown that several chemoattractants stimulate the tyrosine phosphorylation of cellular proteins and that tyrosine kinases are involved in the chemotaxis of leukocytes stimulated by these chemoattractants (Rodriguez-Frade et al., 1999; Wang et al., 2000). We examined the effects of WKYMVM or LXA4 at the tyrosine phosphorylation level in human neutrophils by Western blotting and by probing with anti–phospho-tyrosine antibodies. When cells were stimulated with either of these agonists, a rapid increase in the phospho-tyrosine of several proteins, including a 70-kDa phosphorylated protein, was observed. These proteins were rapidly tyrosyl-phosphorylated (in less than 5 min) and dephosphorylated 30 min after stimulation with WKYMVM or LXA4 (data not shown). We examined the identity of p70 by Western blotting with anti-phospho (Y118) paxillin antibody. As shown in Fig. 3B, stimulation of the cells with 100 nM of WKYMVM or with 1 µM of LXA4 caused rapid tyrosine phosphorylation of paxillin. This suggests that the occupation of FPRL1 elicits the activation of tyrosine kinases, such as p125 FAK, thus resulting in the phosphorylation of paxillin. Next, we decided to investigate whether tyrosine kinase activity is required for WKYMVM- or LXA4-induced neutrophil chemotaxis. Preincubation of human neutrophils with various concentrations of genistein for 15 min at 37°C, before stimulation with WKYMVM or LXA4, did indeed affect neutrophil chemotaxis in a concentration-dependent manner (Fig. 3C). These results indicate that WKYMVM and LXA4 elicit the tyrosyl-phosphorylation of several proteins and that this signaling is required for the chemotaxis of human neutrophils.

View larger version (31K): [in this window] [in a new window]   Fig. 3. WKYMVM- and LXA4-induced neutrophil chemotaxis. Assays were performed using a modified Boyden chamber assay, as described under Materials and Methods. Various concentrations of WKYMVM or LXA4 were loaded into the lower chambers. A, isolated human neutrophils (1 x 106 cells/ml of serum-free RPMI 1640 medium) were added to the upper wells of a 96-well chemotaxis chamber and allowed to migrate across a polycarbonate membrane with a pore size of 3 µm; migration was assessed after 2 h of incubation at 37°C. B, human neutrophils were stimulated with 100 nM of WKYMVM or with 1 µM of LXA4 for the indicated lengths of time. Each sample (30 µg of protein) was subjected to 8% SDS-PAGE, and phosphorylated paxillin was determined by immunoblot analysis with anti-phospho (Y118) paxillin antibody. The shown digits are the quantitative result of paxillin phosphorylation. Immunoblot analysis with anti-actin antibody was conducted to confirm that the same amounts of protein were loaded. The results shown are representative of three independent experiments. C, to test the effect of tyrosine kinase on WKYMVM- or LXA4-induced neutrophil chemotaxis, prepared human neutrophils were exposed to 100 nM of WKYMVM or 300 nM of LXA4 in the absence or in the presence of various concentrations of genistein. The numbers of cells that had migrated were determined by counting in a high-power field (400x). Data are presented as means ± S.E.M. of three independent experiments, each performed in duplicate (A and C).

WKYMVM but Not LXA4 Stimulates Superoxide Generation. One of the major physiological functions of classic chemoattractants, including fMLF, is the production of reactive oxygen species such as superoxide (Baggiolini et al., 1993; Bokoch, 1995). In this study, we compared the effects of WKYMVM and LXA4 on superoxide generation in neutrophils. WKYMVM (100 nM) caused superoxide generation in human neutrophils and was similar to 1 µM of fMLF in this respect (Fig. 4). LXA4, however, did not affect superoxide generation at the 1-µM level (Fig. 4). We also confirmed that superoxide was not generated at concentrations of LXA4 in the range of 1 to 500 nM (data not shown). These results indicate that WKYMVM induces chemotaxis and superoxide generation and that LXA4 only stimulates chemotaxis but not superoxide generation in human neutrophils.

View larger version (26K): [in this window] [in a new window]   Fig. 4. Effects of WKYMVM and LXA4 on superoxide generation in neutrophils. Isolated human neutrophils (2 x 106 cells/100 µl/assay) were preincubated for 1 min at 37°C with 50 µM of cytochrome c before being stimulated with 100 nM WKYMVM, 1 µM LXA4, or 1 µM fMLF. Cytochrome c reduction was monitored as a change in absorption at 550 nm at 1-min intervals over 5 min, as described under Materials and Methods.

WKYMVM and LXA4 Stimulate PLD Activity. Phosphatidic acid, a product of PLD, has been suggested to play a critical role in the activation of the NADPH oxidase complex, resulting in superoxide generation (Perry et al., 1992; Bae et al., 2000). Figure 4 shows that superoxide generation was induced by WKYMVM but not by LXA4. One of the possible reasons for this differential effect concerns the activation status of PLD. We examined the effect of WKYMVM or LXA4 on PLD activity in neutrophils by measuring PBt formation in the presence of butan-1-ol. WKYMVM treatment caused PBt formation in a concentration-dependent manner, showing maximal activity at 100 nM (Fig. 5A). Stimulation of neutrophils with 100 nM of WKYMVM elicited transient PBt formation (Fig. 5B). Neutrophils treated with 30 to 1,000 nM of LXA4 showed similar transient PBt formation (Fig. 5, A and B). In terms of the signaling pathways of WKYMVM- and LXA4-induced PLD activation, it was observed that PLD activation by WKYMVM or LXA4 was sensitive to GF109203X and Ro-31–8220, which suggests the involvement of PKC in this process (Fig. 5C).

View larger version (34K): [in this window] [in a new window]   Fig. 5. Effects of WKYMVM and LXA4 on PBt formation in neutrophils. Isolated human neutrophils were labeled with [3H]myristic acid for 90 min at 37°C in RPMI 1640 medium with 10% FBS. After three washes with phosphate-buffered saline, the labeled cells were stimulated with various concentrations of WKYMVM or LXA4 in the presence of 0.5% butan-1-ol for 10 min (A) or with 100 nM WKYMVM or 1 µM LXA4 in the presence of 0.5% butan-1-ol for various times (B). C, the neutrophils were suspended in RPMI 1640 medium and incubated for 15 min in the presence or absence of 5 µM GF109203X, 5 µM Ro-31–8220, and 50 µM LY294002 at 37°C and then stimulated for 10 min with 100 nM WKYMVM or 1 µM LXA4. PBt was resolved from total lipids by thin-layer chromatography. A Fuji BAS-2000 instrument was used to quantify each lipid. Data are presented as means ± S.E.M. of three separate experiments.

WKYMVM but Not LXA4 Stimulates AA Release. PLA₂ activation is regarded as an important requirement for the activation of the superoxide-generating machinery (Dana et al., 1998; Bae et al., 2000). We investigated the effect of WKYMVM and LXA4 on PLA₂ activity by measuring AA release in neutrophils. As shown in Fig. 6A, WKYMVM at 10 to 1,000 nM stimulated AA release, which leveled off at approximately 5 min (Fig. 6B); however, LXA did not affect AA release significantly at concentrations lower than 1 µM. This is a very interesting result in view of the fact that LXA4 stimulated [Ca²⁺]_i increase and PLD activation in neutrophils. To identify the isozyme of PLA₂ activated by WKYMVM, we examined the effects of different isozyme-specific PLA₂ inhibitors on WKYMVM-induced AA release. Pretreatment with AACOCF₃ (an inhibitor for cPLA₂) or with MAFP (an inhibitor for cPLA₂ and iPLA₂) before the WKYMVM stimulation of neutrophils significantly blocked the WKYMVM-induced AA release (Fig. 6C), whereas preincubation of the cells with BEL (an inhibitor for iPLA₂) did not affect WKYMVM-stimulated AA release (Fig. 6C). This result implies that WKYMVM stimulates cPLA₂ but not iPLA₂ activity in neutrophils. A previous report has demonstrated that ERK activity is important for cPLA₂ phosphorylation and activation (Gijon and Leslie, 1999). We examined the role of ERK on WKYMVM-induced cPLA₂ activation using PD98059, an inhibitor of MAPK kinase. Pretreatment of neutrophils with PD98059 before WKYMVM stimulation elicited the partial inhibition of WKYMVM-induced AA release, indicating the participation of mitogen-activated protein kinase kinase-dependent ERK activity (Fig. 6C).

View larger version (28K): [in this window] [in a new window]   Fig. 6. Effect of WKYMVM and LXA4 on AA release in neutrophils. Human neutrophils preloaded with [3H]AA were stimulated with various concentrations of WKYMVM or 1 µM LXA4 for 30 min (A) and for various periods of time with 100 nM of WKYMVM or 1 µM of LXA4 (B) in the presence of 0.1% fatty acid-free BSA at 37°C. C, the neutrophils were suspended in Hanks' balanced salt solution containing 0.1% fatty acid-free BSA; incubated with MAFP (20 µM for 15 min), AACOCF3 (20 µM for 15 min), BEL (20 µM for 15 min), or PD98059 (50 µM for 60 min) at 37°C; and stimulated for 30 min with 100 nM WKYMVM or vehicle. The neutrophils were then suspended in Hanks' balanced salt solution containing 0.1% fatty acid-free BSA, and stimulated for the predetermined times with the indicated concentrations of WKYMVM, LXA4, or vehicle. Release of [3H]AA into the extracellular medium was determined using a liquid scintillation counter. Results are expressed as percentages of total cellular radioactivity and are presented as mean values ± S.E.M. (n = 6).

WKYMVM but Not LXA4 Stimulates Mitogen-Activated Protein Kinases Activities. The results that WKYMVM, but not LXA4, stimulated cPLA₂ activation in a PD98059-sensitive manner (Fig. 6C) led us to investigate the effect of WKYMVM or LXA4 on MAPK activation in human neutrophils. Accordingly, the effects of various concentrations of WKYMVM or LXA4 were studied on isolated human neutrophils. It was observed that the phosphorylation of ERKs was mediated by WKYMVM but not by LXA4 (Fig. 7, A and B). Moreover, WKYMVM-induced ERK phosphorylation was concentration-dependent and showed maximal activity at 300 nM (Fig. 7A). When we treated the cells with 1 µM of WKYMVM, ERK phosphorylation increased in a time-dependent manner, and maximal activity was reached after 5 min (Fig. 7B). However, in the case of the LXA4-stimulated cells, no significant change in the phosphorylation level of ERKs was detected (Fig. 7, A and B). JNK phosphorylation was also monitored by Western blot analysis using anti–phospho-JNK antibody and was found to be induced by WKYMVM treatment but not by LXA4 treatment (Fig. 8, A and B). These results indicate that the stimulation of FPRL1 by WKYMVM, but not by LXA4, induces the activation of signaling pathways that lead to the activation of ERKs and JNK.

View larger version (51K): [in this window] [in a new window]   Fig. 7. Activation of ERKs by WKYMVM but not by LXA4. Human neutrophils were stimulated with various concentrations of WKYMVM or LXA4 for 5 min (A) or with 100 nM of WKYMVM or 1 µM of LXA4 for various times (B). Each sample (30 µg of protein) was subjected to 8% SDS-PAGE, and phosphorylated ERK levels were determined by immunoblot analysis with anti–phospho-ERK antibody. Immunoblot analysis with anti-ERK antibody was performed to confirm that the same amounts of proteins were loaded. The results shown are representative of at least two independent experiments.

View larger version (46K): [in this window] [in a new window]   Fig. 8. Activation of JNK by WKYMVM but not by LXA4. Human neutrophils were stimulated with various concentrations of WKYMVM or LXA4 for 5 min (A) or with 100 nM of WKYMVM or 1 µM of LXA4 for various times (B). Each sample (30 µg of protein) was subjected to 8% SDS-PAGE, and phosphorylated JNK was determined by immunoblot analysis with anti–phospho-JNK antibody. Immunoblot analysis with anti-JNK antibody was performed to confirm that the same amounts of proteins were loaded. The results shown are representative of at least two independent experiments.

Both cPLA₂ and PLD Activities Are Essential for Superoxide Generation in Neutrophils. In Fig. 4, we showed that WKYMVM but not LXA4 stimulated superoxide generation in human neutrophils. Previously, we reported on the independent functioning of cPLA₂ and PLD on chemoattractant-induced superoxide generation in human monocytes (Bae et al., 2000). In terms of the signaling mechanisms involved in the differential activation of the superoxide-generating machinery by WKYMVM and LXA4, we suspected a differential role of MAPK in mediating cPLA₂ activation and PLD activation. Furthermore, in the present study, WKYMVM-induced superoxide generation was almost completely ablated by cPLA₂ inhibitors (AACOCF₃ and MAFP) or by a phosphatidic acid acceptor (butan-1-ol) (Fig. 9). The iPLA inhibitor (BEL) or control alcohol not acting as a phosphatidic acid acceptor (butan-3-ol) did not affect superoxide generation induced by WKYMVM (Fig. 9). The result indicates that both of cPLA₂ and PLD activation are essential for the activation of the NADPH oxidase complex. Because WKYMVM stimulates both PLA₂ and PLD activation, it can induce superoxide generation in neutrophils. However, in the case of LXA4, PLD is activated but PLA₂ is not, which leads to the lack of cellular superoxide generation in neutrophils.

View larger version (23K): [in this window] [in a new window]   Fig. 9. Effect of WKYMVM-evoked stimulation of cPLA2 and PLD on superoxide generation in neutrophils. Neutrophils were incubated for 15 min in the presence or absence of 20 µM of MAFP, 20 µM of AACOCF3, or 20 µM of BEL at 37°C and stimulated for 5 min with 100 nM WKYMVM. Butan-1-ol (0.4%) or butan-3-ol (0.4%) was added just before stimulation with 100 nM WKYMVM for 5 min. Cytochrome c reduction was monitored as a change in absorption at 550 nm over 5 min, as described under Materials and Methods. Data are presented as means ± S.E.M. of three separate experiments.

WKYMVM and LXA4 Induce Different Signaling in FPRL1-Expressing RBL-2H3 Cells. To further support our notion that WKYMVM and LXA4 differentially stimulate human neutrophils via FPRL1 activation, we investigated the effects of WKYMVM and LXA4 on [Ca²⁺]_i increase and ERK activation in FPRL1-expressing RBL-2H3 cells. As shown in Fig. 10A, stimulation of FPRL1-expressing RBL-2H3 cells with 1 µM WKYMVM or with 1.4 µM LXA4 elicited [Ca²⁺]_i increase. Because no significant [Ca²⁺]_i increase was seen in response to WKYMVM or LXA4 in vector-expressing RBL-2H3 cells (Fig. 10B), the result indicates that both agonists stimulate FPRL1, resulting in [Ca²⁺]_i increase. We also tested the effects of the two agonists on ERK activation in FPRL1-expressing RBL-2H3 cells. Stimulation of FPRL1-expressing RBL-2H3 cells with 1 µM WKYMVM caused transient phosphorylation of ERKs in a time-dependent manner (Fig. 10C). However, when we stimulated FPRL1-expressing RBL-2H3 cells with 1.4 µM LXA4, we could not observe any significant enhancement of phosphorylation of ERKs (Fig. 10C). To confirm whether WKYMVM-induced ERK phosphorylation was mediated by the activation of FPRL1, we investigated the effect of WKYMVM or LXA4 on ERK phosphorylation in vector-expressing RBL-2H3 cells. As shown in Fig. 10D, neither WKYMVM nor LXA4 stimulated ERK phosphorylation in vector-expressing RBL-2H3 cells. The results indicate that although WKYMVM stimulates FPRL1, resulting in both [Ca²⁺]_i increase and ERK activation, LXA4 stimulates [Ca²⁺]_i increase but not ERK activation.

View larger version (41K): [in this window] [in a new window]   Fig. 10. Differential signaling of WKYMVM or LXA4 in FPRL1-expressing RBL-2H3 cells. FPRL1-expressing RBL-2H3 cells (A) or vector-transfected RBL-2H3 cells (B) were loaded with 3 µM fura-2/AM for 50 min at 37°C in serum-free RPMI 1640 medium and washed three times with serum-free RPMI 1640. Before measurement, the cells (2 x 106) were suspended in Ca2+-free Locke solution containing 0.2 mM EGTA. Fura-2–loaded cells were stimulated with 100 nM of WKYMVM or 1.4 µM of LXA4. The charts shown are from a single experiment and are representative of three independent experiments. FPRL1-expressing RBL-2H3 cells (C) or vector-transfected RBL-2H3 cells (D) were stimulated with 100 nM WKYMVM or 1.4 µM of LXA4 for various times. Each sample (30 µg of protein) was subjected to 8% SDS-PAGE and phosphorylated ERK levels were determined by immunoblot analysis with anti–phospho-ERK antibody. Immunoblot analysis with anti-ERK antibody was performed to confirm that the same amounts of proteins were loaded. The results shown are representative of four independent experiments.

	Discussion

Top Abstract Materials and Methods Results Discussion References

 
Phagocytic leukocytes play a key role in innate immune responses, and classic chemotactic peptide receptors such as FPR or FPRL1 are involved in the modulation of this phagocyte activity (Le et al., 2001b). Although the signaling mechanisms of FPR have been well studied, the signaling pathways of FPRL1 have not been investigated systematically. In the present study, we examined the events downstream of FPRL1 in human neutrophils and found that the activation of FPRL1 caused Ca²⁺ increase via PLC- activation in a PTX-sensitive manner, resulting in PKC/PLD-mediated NADPH oxidase stimulation. FPRL1 stimulation also caused PI3K activity-dependent Akt (data not shown) or ERK activation that elicited cPLA₂ activation. Nonreceptor tyrosine kinases, such as FAK, were also activated (data not shown), and this FAK activity induced paxillin phosphorylation.

Although the role of chemotactic peptide receptors is generally regarded to be important, and many different ligands for receptors have been identified, the differential modulation of receptors has not been investigated. In the past, the activation of one chemoattractant receptor by different ligands has been regarded to induce the same cellular signaling and physiological responses. In this study, we suggest for the first time that FPRL1, a chemoattractant receptor, can be activated in a ligand-specific manner by WKYMVM or LXA4. WKYMVM, a peptide ligand of FPRL1, was found to stimulate superoxide generation and chemotactic migration in neutrophils by activating Ca²⁺ increases, MAPKs, cPLA₂, PLD, and paxillin. However, LXA4 could stimulate chemotactic migration but not superoxide generation in human neutrophils. In terms of the associated cellular signaling, LXA4 stimulated Ca²⁺ increase and PLD and paxillin phosphorylation but not the activation of MAPKs and PLA₂, which are essential for superoxide generation. With the neutrophil data, it was still unclear whether another receptor could be involved in the WKYMVM-stimulated neutrophil signaling. However, we subsequently demonstrated that differential signaling of FPRL1 in terms of Ca²⁺ increase and ERK activation was induced by WKYMVM or LXA4 in FPRL1-expressing RBL-2H3 cells but not in vector-transfected RBL-2H3 cells (Fig. 10). Taking our results together, it is reasonable to assume that FPRL1 can mediate distinct cellular signals and functional modulations by ligating different agonists in human neutrophils.

Recent reports have suggested that GPCRs could be modulated in a ligand-specific manner (Robb et al., 1994; Palanche et al., 2001), and ligand-specific GPCR modulation has been found to cause the activation of signaling molecules such as adenylate cyclase (Palanche et al., 2001). In the present study, we show that although WKYMVM and LXA4 stimulate neutrophils and that this results in [Ca²⁺]_i increase (Fig. 1A), the activation of MAPKs was induced by WKYMVM but not by LXA4 (Figs. 7 and 8). To the best of our knowledge, this is the first time that MAPKs such as ERKs and JNK could be differentially modulated via the activation of the same receptor by different ligands. Concerning the mechanism involved in the differential modulation of one GPCR by different ligands, ligand-specific receptor active states have been suggested (Kenakin, 2001). Distinct receptor conformational change induced by different ligands may cause differential coupling patterns of receptor and the heterotrimeric G proteins, which results in the differential activation of effector molecules (Kenakin, 2001). Many chemoattractant receptors, including FPRL1, which is coupled to PTX-sensitive G proteins, induce diverse intracellular signaling through the transient coupling of the subunits of G protein to effector molecules (Bokoch, 1995; Le et al., 2001b). Two of the major effector molecules of the G subunits are PLC and PI3K (Metjian et al., 1999; Scott et al., 2001). Activation of PLC induces intracellular Ca²⁺ increases and PKC activation, which are essential for the activation of PLD (Bacon et al., 1995). PI3K, however, induces Ras/Raf-mediated ERK activation (Avdi et al., 1996) and Akt activation by modulating PDK1 (Sasaki et al., 2000). Previous report demonstrated that different combinations of G subunits selectively modulate distinct phospholipid-dependent enzymes such as PLC or PI3K (Maier et al., 2000). Taking together the previous report (Maier et al., 2000) and our data, it is possible that a distinct combination of G subunits will be involved in the activation of PLC or PI3K in the downstream of FPRL1, resulting in [Ca²⁺]_i increase or ERK activation. Because the binding of LXA4 to FPRL1 could stimulate [Ca²⁺]_i increase/PLD but not ERK/cPLA₂, it seems that the associated ligand binding-induced GPCR conformational change disables G subunit coupling with PI3K. LXA4 also failed to stimulate Akt activity, the downstream event of PI3K of FPRL1 by WKYMVM (data not shown).

Several different FPRL1 ligands have been identified. They include host-derived agonists (LL-37 and SAA), HIV Env domains (F peptide and V3 peptide), and the synthetic peptides (MMK-1 and WKYMVM) (Le et al., 1999, 2001b; Chiang et al., 2000; Christophe et al., 2001). MMK-1 was originally derived from a random peptide library and was identified by a novel autocrine selection method in yeasts engineered to express human FPRL1 (Klein et al., 1998). MMK-1 is a specific chemotactic factor for FPRL1-transfected human embryonic kidney 293 cells and an inducer of Ca²⁺ increase through FPRL1 (Klein et al., 1998). Recently, Serhan et al. demonstrated that two different ligands of FPRL1 (LXA4 and MMK-1) could compete with each other (Chiang et al., 2000). FPRL1 has been reported to be N-glycosylated at the NH₂ terminus (Asn-4) and at the second extracellular loop (Asn-179) (Chiang et al., 2000). Moreover, these N-glycosylated moieties are regarded to be an important feature of intracellular trafficking (Ludwig et al., 2000). Deglycosylation of FPRL1 was reported to dramatically decrease the binding of the peptide ligand MMK-1 but not that of LXA4 (Chiang et al., 2000), which demonstrated the divergent domain requirements of LXA4 and MMK-1 for FPRL1. The FPRL1 binding site for WKYMVM has not been characterized. However, preliminary data suggest the possibility that LXA4 and WKYMVM interact with nonoverlapping sites on FPRL1. For example, pretreatment of neutrophils as well as FPRL1-expressing RBL-2H3 cells with LXA4 does not block subsequent activation of ERK, JNK, and PLA₂ by WKYMVM (data not shown), despite the observed desensitization between the two ligands (Fig. 2). This result is consistent with those published by Serhan and colleagues (Chiang et al., 2000) and together indicates a different structural requirement for LXA4 interaction with FPRL1. We believe that WKYMVM and LXA4 can induce differential intracellular signaling by binding to the differential sites of FPRL1.

The activation of MAPKs such as ERKs, JNK, or p38 kinase is essential to transcriptional activation of many inflammatory cytokines (Craig et al., 2000). Generally, the stimulation of chemoattractant receptors that are coupled to PTX-sensitive GPCRs is known to induce MAPK activation (Bokoch, 1995). Recently, Hu et al. (2001) reported that FPRL1 activation by MMK-1 enhanced proinflammatory cytokine production in human monocytes. We also found that WKYMVM stimulation caused IL-6 production and showed PD98059 sensitivity in monocytes (data not shown), which indicates that WKYMVM-induced IL-6 production is ERK activity-dependent. Knowing that chemoattractant receptor activation-induced cytokine production is MAPK activity-dependent, it is apparent that the failure to activate MAPKs when LXA4 binds to its receptor would not cause proinflammatory cytokine production. Previous reports suggested that LXA4 plays an anti-inflammatory role in immune responses (Takano et al., 1997). Recalling that the production of several proinflammatory cytokines and superoxide generation are mediators of inflammatory responses, the failure of MAPK activation or superoxide generation will illustrate a possible differential role of LXA4 against peptide ligands for FPRL1.

In conclusion, although both WKYMVM and LXA4 bind to FPRL1, a classic chemoattractant receptor in human neutrophils, they transmit differential downstream signals. Functionally, the chemotactic migratory effects overlap; however, superoxide generation is only seen with WKYMVM. We suggest for the first time that FPRL1 is modulated differentially in a ligand-specific manner.

	Footnotes

 
This study was supported by grant FPR02A5-43-110 of 21C Frontier Functional Proteomics Project from Korean Ministry of Science and Technology, the POSCO innovative research project, and the Medical Science and Engineering Research Center for Cancer Molecular Therapy from the Korea Science and Engineering Foundation. R.H. and R.D.Y. are supported by United States Public Health Service grant AI33503.

ABBREVIATIONS: fMLF, formyl-methionyl-leucyl-phenylalanine; PTX, pertussis toxin; GPCR, G protein-coupled receptor; FPR, formyl peptide receptor; PLC, phospholipase C; PI3K, phosphoinositide-3-kinase; MAPK, mitogen-activated protein kinase; PLA₂, phospholipase A₂; cPLA₂, cytosolic phospholipase A₂; iPLA₂, calcium-independent phospholipase A₂; PLD, phospholipase D; FPRL1, formyl peptide receptor-like 1; WKYMVM, Trp-Lys-Tyr-Met-Val-Met-NH₂; ERK, extracellular signal-regulated protein kinase; AA, arachidonic acid; PBt, phosphatidylbutanol; GF109203X, 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)-maleimide; Ro-31–8220, 3-[1-[3-(amidinothio)propyl-1H-indol-3-yl]-3-(1-methyl-1H-indol-3-yl) maleimide methane sulfonate]; LY294002, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; LXA4, lipoxin A4, 5(S),6(R),15(S)-trihydroxyeicosa-7E,9E,11Z,13E-tetraenoic acid; MAFP, methyl arachidonylfluorophosphonate; AACOCF₃, arachidonyltrifluoromethyl ketone; BEL, bromoenol lactone; Y118, phospho-paxillin; A42, amyloid peptide 1–42; IL, interleukin; JNK, c-Jun NH₂-terminal kinase; FBS, fetal bovine serum; BSA, bovine serum albumin; PKC, protein kinase C; FAK, focal adhesion kinase; PAGE, polyacrylamide gel electrophoresis; PD98059, 2'-amino-3'-methoxyflavone.

Address correspondence to: Sung Ho Ryu, Ph.D., Division of Molecular and Life Sciences, Pohang University of Science and Technology, San 31, Hyojadong, Pohang, 790-784, Korea. E-mail: sungho{at}postech.ac.kr

	References

Top Abstract Materials and Methods Results Discussion References

 
Alemany R, Sichelschmidt B, zu Heringdorf DM, Lass H, van Koppen CJ, and Jakobs KH (2000) Stimulation of sphingosine-1-phosphate formation by the P2Y₂ receptor in HL-60 cells: Ca²⁺ requirement and implication in receptor-mediated Ca²⁺ mobilization, but not MAP kinase activation. Mol Pharmacol 58: 491–497.[Abstract/Free Full Text]

Avdi NJ, Winston BW, Russel M, Young SK, Johnson GL, and Worthen GS (1996) Activation of MEKK by formyl-methionyl-leucyl-phenylalanine in human neutrophils. Mapping pathways for mitogen-activated protein kinase activation. J Biol Chem 271: 33598–33606.[Abstract/Free Full Text]

Bacon KB, Flores-Romo L, Life PF, Taub DD, Premack BA, Arkinstall SJ, Wells TN, Schall TJ, and Power CA (1995) IL-8-induced signal transduction in T lymphocytes involves receptor-mediated activation of phospholipases C and D. J Immunol 154: 3654–3666.[Abstract]

Bae YS, Bae H, Kim Y, Lee TG, Suh PG, and Ryu SH (2001) Identification of novel chemoattractant peptides for human leukocytes. Blood 97: 2854–2862.[Abstract/Free Full Text]

Bae YS, Kim Y, Kim JH, Lee TG, Suh PG, and Ryu SH (2000) Independent functioning of cytosolic phospholipase A2 and phospholipase D1 in Trp-Lys-Tyr-Met-Val-D-Met-induced superoxide generation in human monocytes. J Immunol 164: 4089–4096.[Abstract/Free Full Text]

Baek SH, Bae YS, Seo JK, Lee YH, Kim JH, Kwun KB, Suh PG, and Ryu SH (1999) Trp-Lys-Tyr-Met-Val-Met activates mitogen-activated protein kinase via a PI-3 kinase-mediated pathway independent of PKC. Life Sci 65: 1845–1856.[CrossRef][Medline]

Baek SH, Seo JK, Chae CB, Suh PG, and Ryu SH (1996) Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries. J Biol Chem 271: 8170–8175.[Abstract/Free Full Text]

Baggiolini M, Boulay F, Badwey JA, and Curnutte JT (1993) Activation of neutrophil leukocytes: chemoattractant receptors and respiratory burst. FASEB J 11: 1004–1010.

Bechoua S and Daniel LW (2001) Phospholipase D is required in the signaling pathway leading to p38 MAPK activation in neutrophil-like HL-60 cells, stimulated by N-formyl-methionyl-leucyl-phenylalanine. J Biol Chem 276: 31752–31759.[Abstract/Free Full Text]

Bokoch GM (1995) Chemoattractant signaling and leukocyte activation. Blood 86: 1649–1660.[Free Full Text]

Chiang N, Fierro IM, Gronert K, and Serhan CN (2000) Activation of lipoxin A₄ receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J Exp Med 191: 1197–1208.[Abstract/Free Full Text]

Christophe T, Karlsson A, Dugave C, Rabiet MJ, Boulay F, and Dahlgren C (2001) The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J Biol Chem 276: 21585–21593.[Abstract/Free Full Text]

Craig R, Larkin A, Mingo AM, Thuerauf DJ, Andrews C, McDonough PM, and Glembotski CC (2000) p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J Biol Chem 275: 23814–23824.[Abstract/Free Full Text]

Dana R, Leto TL, Malech HL, and Levy R (1998) Essential requirement of cytosolic phospholipase A2 for activation of the phagocyte NADPH oxidase. J Biol Chem 273: 441–445.[Abstract/Free Full Text]

Gijon MA and Leslie CC (1999) Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J Leukoc Biol 65: 330–336.[Abstract]

He R, Tan L, Browning DD, Wang JM, and Ye RD (2000) The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor. J Immunol 165: 4598–4605.[Abstract/Free Full Text]

Hu JY, Le Y, Gong W, Dunlop NM, Gao JL, Murphy PM, and Wang JM (2001) Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. J Leukoc Biol 70: 155–161.[Abstract/Free Full Text]

Jiang H, Kuang Y, Wu Y, Smrcka A, Simon MI, and Wu D (1996) Pertussis toxin-sensitive activation of phospholipase C by the C5a and fMet-Leu-Phe receptors. J Biol Chem 271: 13430–13434.[Abstract/Free Full Text]

Kenakin T (2001) Inverse, protean and ligand-selective agonism: matters of receptor conformation. FASEB J 15: 598–611.[Abstract/Free Full Text]

Klein C, Paul JI, Sauvé K, Schmidt MM, Arcangeli L, Ransom J, Trueheart J, Manfredi JP, Broach JR, and Murphy AJ (1998) Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast. Nat Biotechnol 16: 1334–1337.[CrossRef][Medline]

Le Y, Gong W, Li B, Dunlop NM, Shen W, Su SB, Ye RD, and Wang JM (1999) Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J Immunol 163: 6777–6784.[Abstract/Free Full Text]

Le Y, Gong W, Tiffany HL, Tumanov A, Nedospasov S, Shen W, Dunlop NM, Gao JL, Murphy PM, Oppenheim JJ, et al. (2001a) Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J Neurosci 21: RC123.

Le Y, Oppenheim JJ, and Wang JM (2001b) Pleiotropic roles of formyl peptide receptors. Cytokine Growth Factor Rev 12: 91–105.[CrossRef][Medline]

Ludwig A, Ehlert JE, Flad HD, and Brandt E (2000) Identification of distinct surface-expressed and intracellular CXC-chemokine receptor 2 glycoforms in neutrophils: N-glycosylation is essential for maintenance of receptor surface expression. J Immunol 165: 1044–1052.[Abstract/Free Full Text]

Maddox JF, Hachicha M, Takano T, Petasis NA, Fokin VV, and Serhan CN (1997) Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J Biol Chem 272: 6972–6978.[Abstract/Free Full Text]

Maier U, Babich A, Macrez N, Leopoldt D, Gierschik P, Illenberger D, and Nurnberg B (2000) G52 is a highly selective activator of phospholipid-dependent enzymes. J Biol Chem 275: 13746–13754.[Abstract/Free Full Text]

Marshall J, Krump E, Lindsay T, Downey G, Ford DA, Zhu P, Walker P, and Rubin B (2000) Involvement of cytosolic phospholipase A2 and secretory phospholipase A2 in arachidonic acid release from human neutrophils. J Immunol 164: 2084–2091.[Abstract/Free Full Text]

Metjian A, Roll RL, Ma AD, and Abrams CS (1999) Agonists cause nuclear translocation of phosphatidylinositol 3-kinase . A G-dependent pathway that requires the p110 amino terminus. J Biol Chem 274: 27943–27947.[Abstract/Free Full Text]

Palanche T, Ilien B, Zoffmann S, Reck MP, Bucher B, Edelstein SJ, and Galzi JL (2001) The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states J Biol Chem 276: 34853–34861.[Abstract/Free Full Text]

Pan ZK, Chen LY, Cochrane CG, and Zuraw BL (2000) fMet-Leu-Phe stimulates proinflammatory cytokine gene expression in human peripheral blood monocytes: the role of phosphatidylinositol 3-kinase. J Immunol 164: 404–411.[Abstract/Free Full Text]

Perry DK, Hand WL, Edmondson DE, and Lambeth JD (1992) Role of phospholipase D-derived diradylglycerol in the activation of the human neutrophil respiratory burst oxidase. Inhibition by phosphatidic acid phosphohydrolase inhibitors. J Immunol 149: 2749–2758.[Abstract]

Rhee SG and Bae YS (1997) Regulation of phosphoinositide-specific phospholipase C isozymes. J Biol Chem 272: 15045–15048.[Free Full Text]

Robb S, Cheek TR, Hannan FL, Hall LM, Midgley JM, and Evans PD (1994) Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems. EMBO (Eur Mol Biol Organ) J 13: 1325–1325.[Medline]

Rodriguez-Frade JM, Vila-Coro AJ, Martin A, Nieto M, Sanchez-Madrid F, Proudfoot AE, Wells TN, Martinez-AC, and Mellado M (1999) Similarities and differences in RANTES- and (AOP)-RANTES-triggered signals: implications for chemotaxis. J Cell Biol 144: 755–765.[Abstract/Free Full Text]

Sasaki T, Irie-Sasaki J, Jones RG, Oliveira-dos-Santos AJ, Stanford WL, Bolon B, Wakeham A, Itie A, Bouchard D, Kozieradzki I, et al. (2000) Function of PI3Kgamma in thymocyte development, T cell activation and neutrophil migration. Science (Wash DC) 287: 1040–1046.[Abstract/Free Full Text]

Scott JK, Huang SF, Gangadhar BP, Samoriski GM, Clapp P, Gross RA, Taussig R, and Smrcka AV (2001) Evidence that a protein-protein interaction `hot spot' on heterotrimeric G protein betagamma subunits is used for recognition of a subclass of effectors. EMBO (Eur Mol Biol Organ) J 20: 767–776.[CrossRef][Medline]

Shepherd PR, Withers DJ, and Siddle K (1998) Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem J 333: 471–490.

Takano T, Fiore S, Maddox JF, Brady HR, Petasis NA, and Serhan CN (1997) Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med 185: 1693–1704.[Abstract/Free Full Text]

Wang JF, Park IW, and Groopman JE (2000) Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C. Blood 95: 2505–2513.[Abstract/Free Full Text]

Wu D, Huang CK, and Jiang H (2000) Roles of phospholipid signaling in chemoattractant-induced responses. J Cell Sci 113: 2935–2940.[Abstract]

This article has been cited by other articles:

				C. Prat, J. Bestebroer, C. J. C. de Haas, J. A. G. van Strijp, and K. P. M. van Kessel A New Staphylococcal Anti-Inflammatory Protein That Antagonizes the Formyl Peptide Receptor-Like 1 J. Immunol., December 1, 2006; 177(11): 8017 - 8026. [Abstract] [Full Text] [PDF]

				I. Nagaoka, H. Tamura, and M. Hirata An Antimicrobial Cathelicidin Peptide, Human CAP18/LL-37, Suppresses Neutrophil Apoptosis via the Activation of Formyl-Peptide Receptor-Like 1 and P2X7. J. Immunol., March 1, 2006; 176(5): 3044 - 3052. [Abstract] [Full Text] [PDF]

				M. Nanamori, X. Cheng, J. Mei, H. Sang, Y. Xuan, C. Zhou, M.-W. Wang, and R. D. Ye A Novel Nonpeptide Ligand for Formyl Peptide Receptor-Like 1 Mol. Pharmacol., November 1, 2004; 66(5): 1213 - 1222. [Abstract] [Full Text] [PDF]

				M. Lenoir, B. Djerdjouri, and A. Perianin Stroma Cell-Derived Factor 1{alpha} Mediates Desensitization of Human Neutrophil Respiratory Burst in Synovial Fluid from Rheumatoid Arthritic Patients J. Immunol., June 1, 2004; 172(11): 7136 - 7143. [Abstract] [Full Text] [PDF]

This Article Abstract